首页 产品目录 分子砌块 按官能团 醇类 (10R,12S)-N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-20-((R)-3-氨基-1-羟基丙基)-12-((2-氨基乙基)氨基)-23-((1S,2S)-1,2-二羟基-2-(4-羟基苯基)乙基)-2,11,15-三羟基-6-((R)-1-羟基乙基)-5,8,14,19,22,25-六氧代四十四氢-1H-二吡咯并[2,1-c:2',1'-l][1,4,7,10,13,16]六氮杂环二十一烯-9-基)-10,12-二甲基十四烷酰胺

(10R,12S)-N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-20-((R)-3-氨基-1-羟基丙基)-12-((2-氨基乙基)氨基)-23-((1S,2S)-1,2-二羟基-2-(4-羟基苯基)乙基)-2,11,15-三羟基-6-((R)-1-羟基乙基)-5,8,14,19,22,25-六氧代四十四氢-1H-二吡咯并[2,1-c:2',1'-l][1,4,7,10,13,16]六氮杂环二十一烯-9-基)-10,12-二甲基十四烷酰胺

(10R,12S)-N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxypropyl)-12-((2-aminoethyl)amino)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,15-trihydroxy-6-((R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl)-10,12-dimethyltetradecanamide

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

162808-62-0

中文名称

(10R,12S)-N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-20-((R)-3-氨基-1-羟基丙基)-12-((2-氨基乙基)氨基)-23-((1S,2S)-1,2-二羟基-2-(4-羟基苯基)乙基)-2,11,15-三羟基-6-((R)-1-羟基乙基)-5,8,14,19,22,25-六氧代四十四氢-1H-二吡咯并[2,1-c:2',1'-l][1,4,7,10,13,16]六氮杂环二十一烯-9-基)-10,12-二甲基十四烷酰胺

英文名称

(10R,12S)-N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxypropyl)-12-((2-aminoethyl)amino)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,15-trihydroxy-6-((R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl)-10,12-dimethyltetradecanamide

别名

CS-1171;Caspofungine;CASPOFUNGIN;CASPORFUNGIN;PneuMocandin B0,1-[(4R,5S)-5-[(2-aMinoethyl)aMino]-N2-(10,12-diMethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-;Caspofungin MK-0991;Aids058650;Aids-058650

标准英文名

(10R,12S)-N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxypropyl)-12-((2-aminoethyl)amino)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,15-trihydroxy-6-((R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl)-10,12-dimethyltetradecanamide

分子式

C52H88N10O15

分子量

1093.33

精确分子量

1092.64

SMILES

CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)C2=CC=C(O)C=C2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O

标准SMILES

CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN

用途

Caspofungin is indicated for the following uses: 1. Empirical therapy for presumed fungal infections in febrile, neutropenic patients (defined as fever >38°C with an absolute neutrophil count [ANC] ≤500 cells/mL or ANC ≤1000 cells/mL with a predicted decline to ≤500 cells/mL); 2. Treatment of invasive candidiasis, including candidemia, intra-abdominal abscesses, peritonitis, and pleural space infections caused by Candida species; 3. Treatment of esophageal candidiasis, particularly in patients who are refractory to or intolerant of other antifungal therapies; 4. Salvage therapy for invasive aspergillosis in patients who are refractory to or intolerant of other antifungal agents such as voriconazole. Additionally, caspofungin is recommended by clinical guidelines (e.g., IDSA and Chinese Society of Critical Care Medicine) as a first-line agent for candidemia and as prophylaxis or targeted therapy for invasive fungal infections in critically ill patients.

InChIKey

JYIKNQVWKBUSNH-WVDDFWQHSA-N

安全信息

SureRoute逆合成路线

1.  162808-62-0 逆合成路线 1

—
—
ACZBXK160
162808-62-0
来源: SureRoute

2.  162808-62-0 逆合成路线 2

—
—
ACZBXK160
162808-62-0
来源: SureRoute

3.  162808-62-0 逆合成路线 3

—
—
ACZBXK160
162808-62-0
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手